Dr William Jenkins
Appointed to the Board
6 May 2009. Senior Independent Director with effect from 1 September 2011
Dr Jenkins is a non-executive director of Allecra Therapeutics GmbH and Apitope International NV. He is also a member of the Scientific Advisory board of BB Biotech Ventures and a member of the Strategic Advisory Board of Chiesi Farmaceutici SpA. He is principal of William Jenkins Pharma Consulting.
William is Chair of the Remuneration Committee and a member of the Nomination Committee.
Key Strengths & Experience
William brings to the Board broad and deep pharmaceutical industry experience following a 30 year career in clinical medicine and research.
Formerly head of Worldwide Clinical Development and Regulatory Affairs for Novartis Pharma AG. William also held similar positions with Ciba Geigy AG and Glaxo.